PROGEN
Prostatype Genomics AB
STSweden
Market capitalizationUSD 2.51MAs of 9/8/2026, 11:59:59 PM
Prostatype Genomics AB (PROGEN) is a publicly traded company listed on Stockholm Exchange and associated with Sweden. Its latest validated market capitalization is USD 2.51M. The latest available share price is SEK 0.18. Institution currently ranks it #26,288 globally by market capitalization.
Global rank#26,288
Country rank#637Sweden
Share priceSEK 0.18end of day
Market capUSD 2.51M
Share priceSEK 0.18
1D change+19.05%
Price history
Adjusted historical share price · SEKPrice history unavailableCurrent market data remains available while historical price coverage is prepared.
Company profile
TickerPROGEN
Primary listingStockholm Exchange
CountrySweden
Institution
Starting or running a U.S. company?
Institution coordinates incorporation, bookkeeping and tax preparation for modern businesses.